Source: SCRIP CITELINE COMMERCIAL Jeeva’s founder and CEO talks to Scrip about how the firm’s clinical trial management platform does away with the need for
Source– BioProcess International The infusion of artificial intelligence (AI) technology in drug development has led to transformative solutions to age-old challenges, reshaping the trajectory from
Delays in clinical trials, worsened by the Inflation Reduction Act (IRA), are now a challenge to patient access to new therapies. Evolving complex regulatory requirements,
Source: PR Web President Biden’s loss of his beloved son to brain cancer in 2015 inspired the Cancer Moonshot initiative. Dr. Harsha Rajasimha’s inspiration for
Source: Telehealth and Medicine Today Clinical trials, the bedrock of medical research, are facing a pervasive challenge that threatens the very foundation of therapeutic development:
Source: HealthIT Answers The landscape of drug development is fraught with escalating costs and formidable challenges. Lengthy timelines, exorbitant expenses, and regulatory hurdles often impede
Source: BioSupply Trends Quarterly CLINICAL TRIALS are the linchpin for bringing new medications to market, and they depend on patient participation. However, stalled patient recruitment
Source: Pharmaceutical Outsourcing In the fast-paced world of biopharmaceuticals, emerging and mid-market companies face significant challenges when bringing innovative drugs to market. One major obstacle
Source: PRWeb The cost of patients dropping out of clinical trials continues to be a major problem for the development of new drugs and treatments
Source: Cision PRweb The value of life-saving drugs for patients suffering from serious diseases is priceless. But the current economic environment is stifling the biopharmaceutical
Jeeva Clinical Trials Inc.
